Skip to main content
Back
Watch Compare

ONCOLYTICS BIOTECH INC

Data quality: 83%
ONCY
NASDAQ Manufacturing Chemicals
$0.96
▲ $0.03 (2.69%)
Mkt Cap: 118.45 M
Price
$1.02
Mkt Cap
118.45 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -20.12 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-1532.26%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio1.12
Interest CoverageN/A

Valuation

PE (TTM|NTM)
-4.12 | -2.76
Below sector avg (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -4.1 -1.5
P/B — 1.6
ROE % — -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

6 analysts
Buy
Current
$0.96
+432.8%
Target
$5.09
$2.93
$4.29
$9.98
Forecast
Forward P/E -2.76
Forward EPS -$0.34
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.34
-$0.42 – -$0.29
 0.0 4
FY2026 -$0.34
-$0.39 – -$0.26
 0.0 4

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.09 N/A —
Q32025 -$0.07 -$0.14 -108.2%
Q22025 -$0.08 -$0.07 +17.3%
Q12025 -$0.09 -$0.08 +11.1%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -28.76 M
ROE N/A ROA -379.31%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -20.12 M
ROIC -1532.26% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.12
Interest Coverage N/A Asset Turnover N/A
Working Capital 743,000 Tangible Book Value -3.80 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.12 Forward P/E -2.76
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -16.98%
Market Cap 118.45 M Enterprise Value 113.25 M
Per Share
EPS (Diluted TTM) -0.30 Revenue / Share N/A
FCF / Share -0.17 OCF / Share -0.17
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 69.95%
SBC-Adj. FCF -23.22 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue —
Net Income -28.76 M
EPS (Diluted) -0.30
Gross Profit —
Operating Income -28.73 M
EBITDA —
R&D Expenses 13.31 M
SG&A Expenses —
D&A —
Interest Expense —
Income Tax 79,000.0

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 7.58 M
Total Liabilities 11.38 M
Shareholders' Equity -3.80 M
Total Debt —
Cash & Equivalents 5.20 M
Current Assets 6.84 M
Current Liabilities 6.10 M